ArticleFrontiers in oncology2020

Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice.

Ilze Mentoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.